Advertisement
Screener

LEMAITRE VASCULAR, INC. (LMAT) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

LEMAITRE VASCULAR, INC. Financing Cash Flow

LEMAITRE VASCULAR, INC. (LMAT) reported Financing Cash Flow of -$8.27 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05

  • LEMAITRE VASCULAR, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$5.05M.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$3.22M.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$3.59M, a 102.19% decline year-over-year.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$2.95M.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) financing activities for fiscal 2025 was -$14.54M, a 109.20% decline from fiscal 2024.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) financing activities for fiscal 2024 was $158.10M.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$7.13M.
  • LEMAITRE VASCULAR, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$9.23M, a 167.39% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2026-06-30-$5.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$8.27M
10-Q · filed 2026-08-05
-$11.86M
derived: sum of 3 quarters · filed 2026-08-05
-$14.81M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$3.22M
10-Q · filed 2026-05-06
-$6.81M
derived: sum of 2 quarters · filed 2026-05-06
-$9.76M
derived: sum of 3 quarters · filed 2026-05-06
-$12.52M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$3.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$6.54M
derived: sum of 2 quarters · filed 2026-02-26
-$9.30M
derived: sum of 3 quarters · filed 2026-08-05
-$14.54M
10-K · filed 2026-02-26
2025-09-30-$2.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$5.71M
derived: sum of 2 quarters · filed 2026-08-05
-$10.95M
10-Q · filed 2025-11-07
$153.13M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$2.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$8.00M
10-Q · filed 2026-08-05
$156.08M
derived: sum of 3 quarters · filed 2026-08-05
$152.93M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$5.24M
10-Q · filed 2026-05-06
$158.84M
derived: sum of 2 quarters · filed 2026-05-06
$155.69M
derived: sum of 3 quarters · filed 2026-05-06
$152.82M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$164.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$160.93M
derived: sum of 2 quarters · filed 2026-02-26
$158.06M
derived: sum of 3 quarters · filed 2026-02-26
$158.10M
10-K · filed 2026-02-26
2024-09-30-$3.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$6.02M
derived: sum of 2 quarters · filed 2025-11-07
-$5.98M
10-Q · filed 2025-11-07
-$8.66M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$2.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
-$2.83M
10-Q · filed 2025-08-06
-$5.52M
derived: sum of 3 quarters · filed 2026-02-26
-$8.64M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$39.00K
10-Q · filed 2025-05-08
-$2.65M
derived: sum of 2 quarters · filed 2026-02-26
-$5.77M
derived: sum of 3 quarters · filed 2026-02-26
-$5.27M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$2.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$5.81M
derived: sum of 2 quarters · filed 2026-02-26
-$5.31M
derived: sum of 3 quarters · filed 2026-02-26
-$7.13M
10-K · filed 2026-02-26
2023-09-30-$3.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
-$2.62M
derived: sum of 2 quarters · filed 2024-11-08
-$4.45M
10-Q · filed 2024-11-08
-$6.57M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$502.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$1.32M
10-Q · filed 2024-08-08
-$3.44M
derived: sum of 3 quarters · filed 2025-02-28
-$5.59M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$1.82M
10-Q · filed 2024-05-10
-$3.95M
derived: sum of 2 quarters · filed 2025-02-28
-$6.09M
derived: sum of 3 quarters · filed 2025-02-28
-$8.68M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$2.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$4.27M
derived: sum of 2 quarters · filed 2025-02-28
-$6.85M
derived: sum of 3 quarters · filed 2025-02-28
-$9.23M
10-K · filed 2025-02-28
2022-09-30-$2.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$4.73M
derived: sum of 2 quarters · filed 2023-11-07
-$7.11M
10-Q · filed 2023-11-07
-$8.27M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$2.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$4.96M
10-Q · filed 2023-08-08
-$6.12M
derived: sum of 3 quarters · filed 2024-02-29
$27.24M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$2.38M
10-Q · filed 2023-05-09
-$3.54M
derived: sum of 2 quarters · filed 2024-02-29
$29.83M
derived: sum of 3 quarters · filed 2024-02-29
$19.29M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$1.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$32.21M
derived: sum of 2 quarters · filed 2024-02-29
$21.67M
derived: sum of 3 quarters · filed 2024-02-29
$13.70M
10-K · filed 2024-02-29
2021-09-30$33.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$22.83M
derived: sum of 2 quarters · filed 2022-11-08
$14.86M
10-Q · filed 2022-11-08
-$6.14M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30-$10.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
-$18.50M
10-Q · filed 2022-08-05
-$39.51M
derived: sum of 3 quarters · filed 2023-03-01
-$45.98M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31-$7.96M
10-Q · filed 2022-05-10
-$28.97M
derived: sum of 2 quarters · filed 2023-03-01
-$35.44M
derived: sum of 3 quarters · filed 2023-03-01
$25.93M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31-$21.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
-$27.48M
derived: sum of 2 quarters · filed 2023-03-01
$33.90M
derived: sum of 3 quarters · filed 2023-03-01
$32.16M
10-K · filed 2023-03-01
2020-09-30-$6.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$54.90M
derived: sum of 2 quarters · filed 2021-11-04
$53.16M
10-Q · filed 2021-11-04
$50.94M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$61.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$59.63M
10-Q · filed 2021-08-05
$57.41M
derived: sum of 3 quarters · filed 2022-02-28
$57.43M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31-$1.74M
10-Q · filed 2021-05-10
-$3.96M
derived: sum of 2 quarters · filed 2022-02-28
-$3.94M
derived: sum of 3 quarters · filed 2022-02-28
-$6.79M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31-$2.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$2.20M
derived: sum of 2 quarters · filed 2022-02-28
-$5.05M
derived: sum of 3 quarters · filed 2022-02-28
-$4.62M
10-K · filed 2022-02-28
2019-09-30$16.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$2.83M
derived: sum of 2 quarters · filed 2020-11-06
-$2.40M
10-Q · filed 2020-11-06
-$3.71M
derived: sum of 4 quarters · filed 2021-03-12
2019-06-30-$2.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$2.42M
10-Q · filed 2020-08-06
-$3.72M
derived: sum of 3 quarters · filed 2021-03-12
-$3.72M
derived: sum of 4 quarters · filed 2021-03-12
2019-03-31$424.00K
10-Q · filed 2020-05-08
-$879.00K
derived: sum of 2 quarters · filed 2021-03-12
-$879.00K
derived: sum of 3 quarters · filed 2021-03-12
-$4.25M
derived: sum of 4 quarters · filed 2021-03-12
2018-12-31-$1.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$1.30M
derived: sum of 2 quarters · filed 2021-03-12
-$4.67M
derived: sum of 3 quarters · filed 2021-03-12
-$4.42M
10-K · filed 2021-03-12
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$3.37M
derived: sum of 2 quarters · filed 2019-11-08
-$3.11M
10-Q · filed 2019-11-08
-$4.18M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30-$3.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$3.11M
10-Q · filed 2019-08-06
-$4.18M
derived: sum of 3 quarters · filed 2020-03-12
-$2.88M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31$257.00K
10-Q · filed 2019-05-06
-$809.00K
derived: sum of 2 quarters · filed 2020-03-12
$489.00K
derived: sum of 3 quarters · filed 2020-03-12
2017-12-31-$1.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$232.00K
derived: sum of 2 quarters · filed 2020-03-12
$80.00K
10-K · filed 2020-03-12
2017-09-30$1.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$1.15M
10-Q · filed 2018-11-02
2017-06-30-$152.00K
10-Q · filed 2018-08-06
2016-12-31-$2.58M
10-K · filed 2019-03-11
2013-12-31$48.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21
-$135.00K
derived: sum of 2 quarters · filed 2014-03-21
-$1.04M
derived: sum of 3 quarters · filed 2014-03-21
-$961.00K
10-K · filed 2014-03-21
2013-09-30-$183.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
-$1.09M
derived: sum of 2 quarters · filed 2013-11-07
-$1.01M
10-Q · filed 2013-11-07
-$1.07M
derived: sum of 4 quarters · filed 2014-03-21
2013-06-30-$906.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
-$826.00K
10-Q · filed 2013-08-09
-$887.00K
derived: sum of 3 quarters · filed 2014-03-21
-$2.14M
derived: sum of 4 quarters · filed 2014-03-21
2013-03-31$80.00K
10-Q · filed 2013-05-08
$19.00K
derived: sum of 2 quarters · filed 2014-03-21
-$1.24M
derived: sum of 3 quarters · filed 2014-03-21
-$2.48M
derived: sum of 4 quarters · filed 2014-03-21
2012-12-31-$61.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21
-$1.32M
derived: sum of 2 quarters · filed 2014-03-21
-$2.56M
derived: sum of 3 quarters · filed 2014-03-21
-$3.16M
10-K · filed 2014-03-21
2012-09-30-$1.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
-$2.49M
derived: sum of 2 quarters · filed 2013-11-07
-$3.10M
10-Q · filed 2013-11-07
-$4.57M
derived: sum of 4 quarters · filed 2014-03-21
2012-06-30-$1.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
-$1.84M
10-Q · filed 2013-08-09
-$3.32M
derived: sum of 3 quarters · filed 2014-03-21
-$4.55M
derived: sum of 4 quarters · filed 2014-03-21
2012-03-31-$602.00K
10-Q · filed 2013-05-08
-$2.08M
derived: sum of 2 quarters · filed 2014-03-21
-$3.31M
derived: sum of 3 quarters · filed 2014-03-21
-$4.04M
derived: sum of 4 quarters · filed 2014-03-21
2011-12-31-$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21
-$2.71M
derived: sum of 2 quarters · filed 2014-03-21
-$3.44M
derived: sum of 3 quarters · filed 2014-03-21
-$3.80M
10-K · filed 2014-03-21
2011-09-30-$1.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
-$1.96M
derived: sum of 2 quarters · filed 2012-11-09
-$2.32M
10-Q · filed 2012-11-09
-$3.43M
derived: sum of 4 quarters · filed 2013-03-27
2011-06-30-$728.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10
-$1.09M
10-Q · filed 2012-08-10
-$2.19M
derived: sum of 3 quarters · filed 2013-03-27
-$2.70M
derived: sum of 4 quarters · filed 2013-03-27
2011-03-31-$360.00K
10-Q · filed 2012-05-03
-$1.46M
derived: sum of 2 quarters · filed 2013-03-27
-$1.97M
derived: sum of 3 quarters · filed 2013-03-27
2010-12-31-$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27
-$1.61M
derived: sum of 2 quarters · filed 2013-03-27
-$2.33M
10-K · filed 2013-03-27
2010-09-30-$510.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$1.23M
10-Q · filed 2011-11-14
2010-06-30-$723.00K
10-Q · filed 2011-08-12
2009-12-31-$376.00K
10-K · filed 2012-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
NovoCure Ltd (NVCR)$1.886B-11.87
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77